Publications

Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors

Schuller M. et al, (2023), Pathogens, 12, 324 - 324

Li X. et al, (2023), GREEN CHEMISTRY

Frank N. et al, (2022), Nature, 611, 721 - 726

Thomaidi M. et al, (2022), ChemMedChem, 17

Iordanidou D. et al, (2022), Molecules (Basel, Switzerland), 27

Shaabani S. et al, (2022), Molecules, 27

Nizami S. et al, (2021), Scientific Reports, 11

Nizami S. et al, (2021), Scientific Reports, 11

Gao K. et al, (2021), RSC Medicinal Chemistry, 12, 809 - 818

Sutanto F. et al, (2021), Science Advances, 7

Nizami S. et al, (2021), Immunology, 162, 84 - 91

Kunig VBK. et al, (2020), Angewandte Chemie (International ed. in English), 59, 20338 - 20342

Neochoritis CG. et al, (2020), Journal of Chemical Education, 97, 3739 - 3745

Clemente GS. et al, (2020), EJNMMI Research, 10

S Clemente G. et al, (2019), Molecules (Basel, Switzerland), 24

Neochoritis CG. et al, (2019), European Journal of Organic Chemistry, 2019, 6132 - 6137

Neochoritis CG. et al, (2019), Science advances, 5

Zarganes-Tzitzikas T. et al, (2019), Molecules (Basel, Switzerland), 24

Zarganes-Tzitzikas T. et al, (2019), ACS Medicinal Chemistry Letters, 10, 389 - 392

Neochoritis CG. et al, (2019), Beilstein Journal of Organic Chemistry, 15, 513 - 520